1 | group on new tb | | | | | | | 8 | 1.44% |
2 | on new tb vaccines | | | | | | | 8 | 1.44% |
3 | working group on new | | | | | | | 7 | 1.26% |
4 | more effective tb vaccines | | | | | | | 4 | 0.72% |
5 | effective tb vaccines by | | | | | | | 4 | 0.72% |
6 | tb vaccines by promoting | | | | | | | 4 | 0.72% |
7 | and investment in tb | | | | | | | 3 | 0.54% |
8 | the working group on | | | | | | | 3 | 0.54% |
9 | build consensus on key | | | | | | | 3 | 0.54% |
10 | the development of new | | | | | | | 3 | 0.54% |
11 | new more effective tb | | | | | | | 3 | 0.54% |
12 | become a member take | | | | | | | 3 | 0.54% |
13 | support and investment in | | | | | | | 3 | 0.54% |
14 | a member take action | | | | | | | 3 | 0.54% |
15 | issues and questions related | | | | | | | 2 | 0.36% |
16 | tb vaccines new vaccines | | | | | | | 2 | 0.36% |
17 | on key issues and | | | | | | | 2 | 0.36% |
18 | the stop tb partnership | | | | | | | 2 | 0.36% |
19 | partnership and the tb | | | | | | | 2 | 0.36% |
20 | consensus on key issues | | | | | | | 2 | 0.36% |
21 | to tb vaccine rd | | | | | | | 2 | 0.36% |
22 | implementation care advocacy and | | | | | | | 2 | 0.36% |
23 | vaccine pipeline resources become | | | | | | | 2 | 0.36% |
24 | care advocacy and tb | | | | | | | 2 | 0.36% |
25 | pipeline resources become a | | | | | | | 2 | 0.36% |
26 | advocacy and tb vaccine | | | | | | | 2 | 0.36% |
27 | vaccines new vaccines are | | | | | | | 2 | 0.36% |
28 | new tb vaccines new | | | | | | | 2 | 0.36% |
29 | new tb vaccines wgnv | | | | | | | 2 | 0.36% |
30 | to discuss challenges to | | | | | | | 2 | 0.36% |
31 | forum to discuss challenges | | | | | | | 2 | 0.36% |
32 | privacy policy · terms of use | | | | | | | 2 | 0.36% |
33 | reserved privacy policy · terms of | | | | | | | 2 | 0.36% |
34 | resources become a member | | | | | | | 2 | 0.36% |
35 | multiple stakeholders providing a | | | | | | | 2 | 0.36% |
36 | the wins4tbvax learn more | | | | | | | 2 | 0.36% |
37 | endorse the wins4tbvax learn | | | | | | | 2 | 0.36% |
38 | new tb vaccines is | | | | | | | 2 | 0.36% |
39 | tb vaccines is hosted | | | | | | | 2 | 0.36% |
40 | priorities tb vaccine pipeline | | | | | | | 2 | 0.36% |